Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001493152-23-002025
Filing Date
2023-01-20
Accepted
2023-01-20 16:06:23
Documents
6
Effectiveness Date
2023-01-20

Document Format Files

Seq Description Document Type Size
1 forms-8.htm S-8 105052
2 ex5-1.htm EX-5.1 13535
3 ex23-1.htm EX-23.1 4294
4 ex23-2.htm EX-23.2 4357
5 ex23-3.htm EX-23.3 4143
6 ex107.htm EX-FILING FEES 21147
  Complete submission text file 0001493152-23-002025.txt   153722
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-269330 | Film No.: 23541017
SIC: 2834 Pharmaceutical Preparations